Boston Massachusetts - Cambridge | U.S.A.
| Investor Type | Firm |
| Industries | BioTech • FinTech (& Financials services) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine) |
| Stages | Seed, Pre-seed |
| Investing | United States |
| Investment Range | $100,000 - $5,000,000 |
| Investment Sweet Spot | $1,500,000 |
| Assets Under Management | $5,000,000,000 |
What is BrightEdge?
BrightEdge is the American Cancer Society’s mission-driven venture capital fund, focusing on patient-centric social innovation and mission-aligned impact investing. With a significant asset base of $5 billion under management, their primary goal is to combat cancer while advancing health equity across various communities. BrightEdge channels its investments toward for-profit companies that are developing novel cancer-focused treatments and technologies, bringing innovation to the market that can save lives and improve cancer care.
The fund typically invests between $100,000 and $5,000,000, with a preferred investment 'sweet spot' of $1,500,000. Their specialty lies in seed and pre-seed stage financing for companies in multiple sectors including BioTech, FinTech & Financial services, HealthTech & Fitness, Medical Devices & Hospital Services, Healthcare & Wellness, Consumer, and Pharmaceuticals & Medicine.
BrightEdge takes a strategic approach to investing, leveraging the American Cancer Society’s expertise to empower entrepreneurs and drive advances in cancer treatment, detection, and prevention. The fund also runs Project HEALTH, an accelerator program designed to amplify the impact of companies developing solutions to address healthcare disparities, reduce access barriers, and promote health equity.
By investing in entrepreneurial early-stage companies, BrightEdge enables the commercialization of a broad spectrum of solutions aimed at tackling cancer from all angles. Their involvement extends beyond financial investment to include supporting companies as they navigate the challenges of bringing compelling solutions to the market, with a potential impact that could affect more than 3.5 million patients and families annually.
Through strategic investment and commitment to fostering a world without cancer, BrightEdge supports the creation of a long-term, sustainable revenue stream for the ACS while offering investors and donors the opportunity to become part of a transformational journey in healthcare innovation and social change.
What are the investment firms similar to BrightEdge
SCB 10X
Metaplanet
Jaza Rift Ventures
Derive Ventures
Manhattan West
VentureDNA
Consumer Ventures
SALT Fund
Erez Capital
Rainforest QA
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 71-75 Shelton Street, Covent Garden, WC2H 9JQ
- London, U.K.
- contact@angelspartners.com
